Anne Cross
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 0.5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Pneumonia and Respiratory Infections
Papers in
- Epidemiology 18
- Hepatitis B Virus Studies 11
- Cytomegalovirus and herpesvirus research 3
-
- HIV/AIDS drug development and treatment 15
- HIV/AIDS Research and Interventions 3
- Co-authors
- Richard J. Colonno (4 shared papers)Zachary Goodman (3 shared papers)Richard B. Wilber (8 shared papers)Anna S. Lok (2 shared papers)Ting‐Tsung Chang (2 shared papers)Deborah DeHertogh (2 shared papers)Jose D. Sollano (7 shared papers)Gerald Wolf (4 shared papers)
- Journals
- Neurology (6 papers)Journal of Hepatology (5 papers)New England Journal of Medicine (5 papers)The Journal of Infectious Diseases (4 papers)Clinical Therapeutics (2 papers)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Anne Cross
41 papers receiving 3.9k citations
Anne Cross's Hit Papers
Peers
Comparison fields: 5 of 125
- Hepatology 1.5k
- Epidemiology 3.0k
- Virology 316
- Infectious Diseases 638
- Internal Medicine 38
Countries citing papers authored by Anne Cross
This map shows the geographic impact of Anne Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Cross more than expected).
Fields of papers citing papers by Anne Cross
This network shows the impact of papers produced by Anne Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Cross. The network helps show where Anne Cross may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Cross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B Hit paper breakdown → | 2006 | 1065 |
| 2 | Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B Hit paper breakdown → | 2006 | 901 |
| 3 | 1986 | 308 | |
| 4 | 2006 | 307 | |
| 5 | 1992 | 256 | |
| 6 | 2013 | 187 | |
| 7 | 1989 | 173 | |
| 8 | 2008 | 146 | |
| 9 | 1993 | 126 | |
| 10 | 1993 | 93 | |
| 11 | 2007 | 82 | |
| 12 | 1995 | 61 | |
| 13 | 1990 | 48 | |
| 14 | 1995 | 48 | |
| 15 | 1986 | 48 | |
| 16 | 1995 | 42 | |
| 17 | 1999 | 30 | |
| 18 | 1991 | 26 | |
| 19 | 1990 | 23 | |
| 20 | 1999 | 23 |
About Anne Cross
Anne Cross is a scholar working on Epidemiology, Infectious Diseases, Virology, Hepatology and Pathology and Forensic Medicine, having authored 43 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (15 papers), Hepatitis B Virus Studies (11 papers), HIV Research and Treatment (9 papers), Hepatitis C virus research (6 papers), Multiple Sclerosis Research Studies (5 papers), Peripheral Artery Disease Management (4 papers), HIV/AIDS Research and Interventions (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Hepatology (1.5k citations), Epidemiology (3.0k citations), Virology (316 citations), Infectious Diseases (638 citations) and Internal Medicine (38 citations). Anne Cross has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Richard J. Colonno, Zachary Goodman, Richard B. Wilber, Anna S. Lok, Ting‐Tsung Chang, Deborah DeHertogh, Jose D. Sollano, Gerald Wolf, Richard C. Zink and Daniel Shouval. Their work appears in journals such as Neurology, Journal of Hepatology, New England Journal of Medicine, The Journal of Infectious Diseases and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.